Activity of venetoclax-based therapy in TP53-mutated acute myeloid leukemia.
暂无分享，去创建一个
M. Konopleva | M. Andreeff | K. Bhalla | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | N. Pemmaraju | N. Short | C. Benton | G. Montalban-Bravo | Mahran Shoukier